Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Baleine & Bjorn Capital, LLC is a venture capital firm founded in 2016 and based in New York, New York. Co-founded by Liz Dee and Nick Garin, the firm focuses on investing in companies that create sustainable and humane alternatives to conventional animal products. B&BC addresses the challenges posed by outdated animal agriculture by supporting innovative solutions in the alternative protein and sustainable food sectors.
As of now, Baleine & Bjorn Capital manages a portfolio of four companies, emphasizing their commitment to the alternative protein market. The firm is actively engaged in the investment landscape, leveraging its connections within the alternative protein advocacy ecosystem, including a board member position at The Good Food Institute. This strategic positioning allows them to provide valuable resources and support to their portfolio companies.
Since its inception, B&BC has established itself as an early mover in the alternative protein investment space, focusing on plant-based and cultured food products. Their approach aligns with a growing demand for sustainable food solutions, reflecting a broader shift in consumer preferences towards ethical and environmentally friendly options.
Baleine & Bjorn Capital specializes in investment opportunities within the alternative protein sector. Their investment strategy is centered on identifying companies that create sustainable and humane alternatives to conventional animal products. This includes a focus on plant-based and cultured food solutions, which are seen as essential in addressing the challenges of traditional animal agriculture.
The firm targets investments across various stages, from seed to growth-equity, allowing them to support companies at different points in their development. Their check sizes are not publicly disclosed, but the firm is known for its active engagement in the alternative protein market, indicating a willingness to invest in promising startups that align with their mission.
B&BC seeks to partner with innovative entrepreneurs who share their vision of promoting sustainability and humane practices in food production. Their investment thesis emphasizes the belief that smart people and sustainable solutions can positively impact the planet and its inhabitants, making them a compelling partner for startups in the food technology space.
Baleine & Bjorn Capital's portfolio includes four notable companies that exemplify their focus on alternative proteins and sustainable food solutions:
These companies reflect Baleine & Bjorn Capital's commitment to investing in innovative solutions that address the environmental and ethical challenges associated with traditional animal agriculture. Their portfolio showcases a diverse range of products, from food to fashion, all centered around the principles of sustainability and humane practices.
Liz Dee - CEO, Co-founder of Baleine & Bjorn Capital. Liz is also a co-owner and co-president of Smarties Candy Company. She serves on the board of The Good Food Institute, leveraging her expertise in the food industry to support sustainable practices.
Nick Garin - Co-founder of Baleine & Bjorn Capital. Nick brings experience in venture capital and a commitment to promoting humane alternatives to conventional animal agriculture.
Founders interested in pitching to Baleine & Bjorn Capital should prepare a detailed pitch deck that includes information about their business model, market opportunity, and alignment with the firm's investment thesis. While specific channels for submission are not disclosed, a warm introduction through mutual connections in the alternative protein space may enhance the chances of engagement.
It is advisable to clearly articulate the startup's mission and how it contributes to sustainable and humane food solutions. Founders should also be prepared for a thorough evaluation process, as B&BC seeks to invest in companies that align closely with their values and objectives.
What are Baleine & Bjorn Capital's investment criteria?
Baleine & Bjorn Capital focuses on companies that create sustainable and humane alternatives to conventional animal products. They specifically target the alternative protein sector, including plant-based and cultured food solutions.
How can I apply or pitch to Baleine & Bjorn Capital?
While specific application procedures are not publicly disclosed, founders interested in pitching should prepare a comprehensive deck that outlines their business model, market opportunity, and alignment with B&BC's mission of sustainability and humane practices.
What makes Baleine & Bjorn Capital different from other investors?
Baleine & Bjorn Capital's unique focus on the alternative protein sector, combined with their deep connections within the advocacy ecosystem, sets them apart. Their board member position at The Good Food Institute enhances their ability to support portfolio companies strategically.
What is the geographic scope of Baleine & Bjorn Capital's investments?
The firm primarily targets the U.S. market, focusing on companies based in the United States that are innovating in the alternative protein space.
What stages of investment does Baleine & Bjorn Capital engage in?
Baleine & Bjorn Capital invests across various stages, including seed, Series A, Series B, and growth-equity, allowing them to support companies at different points in their growth journey.
What kind of post-investment involvement can portfolio companies expect?
Baleine & Bjorn Capital adds value to its portfolio companies by leveraging its extensive network and providing strategic support. Their connections within the alternative protein advocacy ecosystem can help companies navigate challenges and enhance their market presence.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.